Join us for the AACE Clinical Guidance Forum, December 10–11, 2025, and be the first to explore the newest AACE guidelines and consensus statements—presented by the experts who created them. This two-evening, virtual CME event offers practical, case-based learning to help you implement evidence-based care in obesity, dyslipidemia, multiple endocrine neoplasia, reproductive endocrinology, and menopause management.

December 10–11, 2025 | 5:00 PM – 9:00 PM EST

REGISTER NOW

Why Attend?

  • Stay at the cutting edge of endocrinology and join the premier virtual event on AACE Clinical Guidance delivering the latest guidelines, evidence-based standards, and emerging innovations.
  • Hear and engage directly from the authors of newly published AACE clinical guidance documents, and engage in expert-led discussions, case-based learning, and interactive sessions.
  • Walk away with practical strategies to improve outcomes, tackle complex cases, and apply the newest advancements in your daily practice.

SCHEDULE
AT A GLANCE

Wednesday, December 10, 2025

5:00 PM – 9:00 PM EST

Day 1

5:00 PM – 5:50 PM EST

CME Pre Session: Transforming Patient Care with the Obesity Algorithm: Practical Insights
(This CME activity is supported by an independent educational grant from Novo Nordisk.)

6:00 PM – 6:05 PM EST

Welcome Message – AACE President Scott Isaacs, MD, FACE, FACP, and AACE CEO Johnnie White 

6:05 PM – 6:10 PM EST

Overview of the conference theme, objectives, and brief introduction to the day’s agenda

6:10 PM – 7:10 PM EST

AACE Consensus Statement: Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity-Based Chronic Disease – 2025 Update

  • Meet the AACE Task Force Members
  • What’s New in the Obesity Algorithm and its implementation
  • Patient Cases
  • Q and A

7:10 PM – 7:25 PM EST

Break

7:25 PM – 8:25 PM EST

AACE Consensus Statement on Management of Multiple Endocrine Neoplasia, Type 1

  • Meet the AACE Task Force Members
  • What’s New in the MEN 1 and its implementation
  • Patient Cases
  • Q and A

8:25 PM – 9:00 PM EST

Wrap Up of Day 1

  • Summary of Key Takeaways
  • Recap of major points from each session

Thursday, December 11, 2025

5:00 PM – 9:00 PM EST

Day 2

5:00 PM – 5:50 PM EST

CME Pre Session: The Evolving Landscape of Adult Dyslipidemia: Current Insights
(This CME activity is supported by an independent educational grant from Novartis Pharmaceuticals.)

6:00 PM – 6:05 PM EST

Welcome to Day 2-Program

6:05 PM – 7:05 PM EST

AACE Clinical Practice Guideline on Pharmacologic Management of Adults with Dyslipidemia

  • Meet the AACE Task Force Members
  • What’s New in the Dyslipidemia CPG and its implementation
  • Patient Cases
  • Q and A

7:05 PM – 8:05 PM EST

AACE Consensus Statement: Algorithm for Management of Adults with Dyslipidemia – 2025 Update

  • Meet the AACE Task Force Members
  • What’s New in the Dyslipidemia Algorithm and its implementation
  • Patient Cases
  • Q and A

8:05 PM – 8:20 PM EST

Break

8:20 PM – 8:55 PM EST

Advances in Managing Menopause - Perimenopause and How Early to Start HRT

  • Patient Cases
  • Q and A

8:55 PM – 9:00 PM EST

Closing Session

 

Program subject to change.

PASSES
AND PRICING

Virtual Pass Registration
2-Day Live Access + On-Demand Content + CME/CE/MOC Credit

Includes 2 days of live virtual engaging panel discussions with the authors of:

PLUS, all content can be accessed on-demand through December 11, 2026

Program is eligible for CME/CE/MOC Credit

REGISTER NOW
AACE Membership Type Early Bird
(Register thru 11/19)		Standard
(Register thru 12/11)
Fellow/Student/Resident Member
(AACE Membership Required)		$65 $115
Engaged Member $95 $145
Informed Member $129 $179
Non-Members$159 $209

Target Audience

The forum is structured to provide relevant, practical and immediate application of AACE’s Clinical Guidance Documents for endocrinologists, fellows, primary care physicians, physicians assistants, nurse practitioners, nurses, diabetes care and education specialists, clinical pharmacists, registered dietitians, and others in the endocrine care team.

Learning Objectives

By the end of this conference, participants will be able to:

  • Evaluate recent updates in clinical guidelines for the management of common endocrine disorders and integrate these recommendations into everyday practice to optimize patient care.
  • Implement strategies to enhance patient engagement, adherence, and clinical outcomes through effective communication and education, with a focus on recognizing and addressing health disparities in diverse and underserved populations.
  • Examine emerging innovations in subspecialty areas of endocrinology and collaborate within multidisciplinary care teams to manage complex endocrine conditions more effectively.

2025 PROGRAM
LEADERS

Chair

Ricardo Correa, MD, EdD, FACP, FACE, FACMQ

Vice Chair

Joanna Miragaya, MD, PhD